Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products
Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products
Stay updated with breaking news from Submit Comments. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products
This document provides recommendations for premarket submissions for orthopedic devices that contain metallic and/or calcium phosphate coatings on the surface.
This is the Draft Guidance for Industry, Potency Assurance for Cellular and Gene Therapy Products
This draft guidance provides FDA’s current thinking on the 510(k) Third Party Review Program and review of EUA requests by third party review organizations.
This guidance assists sponsors pursuing Priority Zoonotic Animal Drug (PZAD) designation of a new animal drug.